Member's Mark

Ultra Triple Action Joint Health

Serving
1 Tablet(s)
Per container
125
Form
tablet
DSLD
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
15
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

3 active ingredients
IngredientAmount% DV
UC-II Proprietary Cartilage Blend
Proprietary Blend (Combination)
401 mg
Boron
UNII · N9E3X5056Q
5 mg
Hyaluronic Acid
Hyaluronic acidUNII · S270N0TRQY
3.3 mg
Flagged excipients

1 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

FDA CAERS · adverse event context
15
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Microcrystalline Cellulose · Croscarmellose Sodium · Magnesium Stearate · Stearic Acid · Silicon Dioxide · Polyvinyl Alcohol · Polyethylene Glycol · Magnesium Silicate · Mica · Polysorbate 80